The U.S. Supreme Court’s refusal May 15 to hear a case about whether a plaintiffs’ law firm has standing to challenge the FDA’s drug labeling actions leaves the issue of when third parties can sue the government as murky as ever (Sheller P.C. v. HHS, U.S., No. 16-1097, cert. denied 5/15/17).
Philadelphia-based law firm Sheller P.C. petitioned the high court to review a 2016 Third Circuit decision finding it didn’t have standing to request the FDA to either yank its approval of Risperdal for use in children or to add a black-box warning about the drug’s side effects in children.
Risperdal, made by J&J subsidiary Janssen Pharmaceuticals Inc., has been linked to gynecomastia, a condition causing abnormal breast growth in boys and young men.
Generally, third parties—who don’t have a direct, personal stake in the matter at hand—can’t sue the government, but courts have allowed third parties to sue in some constitutional cases involving fundamental rights, constitutional scholar and standing expert Bradford Mank, James Helmer, Jr. professor at the University of Cincinnati College of Law, told me.
Third Parties Have Additional Hurdles
The Supreme Court has required parties seeking third-party standing to make two additional showings, Mank said.
Those involve whether the party asserting the right has a “close” relationship with the person who possesses the right and whether there is a “hindrance” to the possessor’s ability to protect his own interests, he said.
“In cases involving First Amendment and other important constitutional rights, the court has been especially willing to allow third-party suits, but in nonconstitutional areas of law, the court has been much less willing to do so.”
The upshot here? Sheller P.C. is out of luck.
Read my full story here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)